AdjuTec Pharma – Phase I Clinical Study Results for APC148 Published
The results demonstrated that APC148 was well tolerated and supported its continued clinical development as a potential solution to combat…
BEAM at work
Our advocacy work is based on analysis and reflection with our members.
Each topic is dealt with by a task force, which acts as a discussion platform and issues policy briefs.
